Literature DB >> 22982005

Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.

Jason Koshy1, You-Wen Qian, Gayathri Bhagwath, Maurice Willis, Todd W Kelley, Peter Papenhausen.   

Abstract

Acute promyelocytic leukemia (APL) is a well-defined subtype of acute myeloid leukemia (AML) specifically characterized by the t(15;17)(q22;q12) translocation. The t(15;17) results in the fusion of the promyelocytic leukemia (PML) and retinoic acid receptor alpha (RARA) genes. Rare cryptic fusions often associated with small genomic insertions can best be detected by reverse transcriptase-polymerase chain reaction (RT-PCR) although conventional chromosomal studies or even fluorescence in situ hybridization (FISH) analyses appear normal. We report here an APL clone with a cryptic PML-RARA fusion that returned negative results by both karyotyping and fluorescence in situ hybridization (FISH), but returned positive results by RT-PCR analysis. A single nucleotide polymorphism (SNP) microarray analysis was used in this case to help resolve the discordance, revealing a 49-kilobase intragenic PML gene duplication. A dual color dual fusion PML-RARA FISH probe set identified a small, extra PML signal in a chromosome other than 15 or 17. Although coinsertion of a RARA sequence could be detected by neither FISH nor array, the RT-PCR positivity is consistent with this fusion "ectopic" to the natural gene loci. The findings highlight the clinical utility of microarray in cases of cryptic PML-RARA fusion. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982005     DOI: 10.1016/j.cancergen.2012.07.017

Source DB:  PubMed          Journal:  Cancer Genet


  7 in total

Review 1.  Diagnostic molecular techniques in haematology: recent advances.

Authors:  Aikaterini Koutsi; Elisavet-Christina Vervesou
Journal:  Ann Transl Med       Date:  2018-06

2.  Value of oligonucleotide-based array comparative genomic hybridization for diagnosis of acute promyelocytic leukemia in a patient negative for t(15;17)(q24.1;q21.2)/promyelocytic leukemia-retinoic acid receptor, alpha by conventional cytogenetics and fluorescence in situ hybridization.

Authors:  Khaled Alayed; L Jeffrey Medeiros; Roger A Schultz; Jorge Cortes; Gary Lu; Carlos E Bueso-Ramos; Sergej Konoplev
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-14

3.  High-Risk Acute Promyelocytic Leukemia with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and Arsenic Trioxide-Based Regimen.

Authors:  Zeba N Singh; Vu H Duong; Rima Koka; Ying Zou; Sameer Sawhney; Li Tang; Maria R Baer; Nicholas Ambulos; Firas El Chaer; Ashkan Emadi
Journal:  J Hematop       Date:  2018-08-09       Impact factor: 0.196

4.  Promyelocytic Leukemia with No Retinoic Acid Receptor Alpha Abnormality but with RUNX1T1 Insertion to Chromosome 7q: A Classification and Management Dilemma.

Authors:  Kathleen Overholt; Terri L Guinipero; Nyla A Heerema; Michael R Loken; Samir B Kahwash
Journal:  Case Rep Hematol       Date:  2015-08-17

5.  Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.

Authors:  Inés Gómez-Seguí; Dolors Sánchez-Izquierdo; Eva Barragán; Esperanza Such; Irene Luna; María López-Pavía; Mariam Ibáñez; Eva Villamón; Carmen Alonso; Iván Martín; Marta Llop; Sandra Dolz; Oscar Fuster; Pau Montesinos; Carolina Cañigral; Blanca Boluda; Claudia Salazar; Jose Cervera; Miguel A Sanz
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

6.  Acute promyelocytic leukemia with a cryptic insertion of RARA into PML on chromosome 15 due to uniparental isodisomy: A case report.

Authors:  Anna Venci; Rita Mazza; Orietta Spinelli; Luciana Di Schiena; Daniela Bettio
Journal:  Oncol Lett       Date:  2017-04-03       Impact factor: 2.967

7.  A simple surface plasmon resonance biosensor for detection of PML/RARα based on heterogeneous fusion gene-triggered nonlinear hybridization chain reaction.

Authors:  Bin Guo; Wei Cheng; Yongjie Xu; Xiaoyan Zhou; Xinmin Li; Xiaojuan Ding; Shijia Ding
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.